Celldex’s cash runway extends into 2027, but potential delays or hurdles could necessitate earlier fundraising, exerting ...

Public works dept targets cell towers By Kimberly Guest, ITWeb contributorJohannesburg, 22 Apr 2025The Department of Public Works and Infrastructure seeks specialists to assist it to manage its ...

Grass and tree pollen counts are at very high levels, and those are the allergens affecting people and causing symptoms of coughing, sneezing and stuffy heads. Tree pollen is predicted by the Weather ...

Jasper Therapeutics, Inc.’s JSPR share price has surged by 7.05%, which has investors questioning if this is right time to ...

Crown Castle refocuses on cell towers, sells fiber division for $8.5B, boosting financial stability, dividends & investor ...

There's nothing better than a beautiful spring day after a long, cold winter. But there's nothing worse than having that day ...

AB Science will be granted a patent, valid through 2040, covering the medical use of masitinib as a treatment for sickle cell ...

Discover natural supplements and practical strategies that can help alleviate seasonal allergy symptoms while reducing ...

A 43-year-old woman presented with 6 months of recurrent bilateral eye pain and redness alongside spontaneous urticaria.She ...

There have been new developments in treatments for chronic spontaneous urticaria, with dupilumab, remibrutinib, and ...

Tumors develop when cells in the body grow uncontrollably. Finding a tumor on your dog can be very frightening, but they are ...

Standard treatment for SCD includes red blood cell transfusions and treatment with hydroxyurea to manage complications, but significant unmet need remains. Mast cells, a major target for masitinib, ...